|

Reduce Loneliness in Care Partners of Persons With AD/ADRD

RECRUITINGN/ASponsored by Northwell Health
Actively Recruiting
PhaseN/A
SponsorNorthwell Health
Started2024-03-06
Est. completion2026-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations4 sites

Summary

More than 60% of care partners of persons with AD/ADRD report feeling lonely. Building on the existing evidence that increasing meaning and purpose in life is a strong predictor of decreased loneliness, interventions to reduce loneliness in this population may be strengthened by incorporating concepts from Meaning-Centered Psychotherapy (MCP). Thus, the overall goal of the proposed project is to reduce loneliness in care partners of patients with AD/ADRD through increasing their sense of meaning and purpose in life using concepts from MCP, delivered via a web-based platform, RELOAD-C (REducing LOneliness in Alzeheimer's Disease-Care Partners). This will be achieved through three Specific Aims. Aim 1 consists of three phases (preparatory work, stakeholder involvement with N=15 AD/ADRD care partners, and adaptation of the existing web-based platform) to produce RELOAD-C, which centralizes: 1) 6 brief videos portraying an MCP expert delivering MCP concepts; 2) links to 7 virtual group meetings (6 weekly + 1 booster) to discuss MCP concepts (of note, the support groups utilized in this study exist only as part of this research); and 3) written content expanding on the material from the MCP videos. Aim 2 evaluates usability/acceptability of RELOAD-C (defined as a task success rate ≥ 78%, and scores ≥ 68 on the System Usability Scale) with N=20 care partners of persons with AD/ADRD. Aim 3 proposes a pilot RCT to evaluate the preliminary efficacy of the RELOAD-C components (MCP videos vs. MCP-focused group discussions) in reducing loneliness and feasibility of conducting a future, large-scale RCT. N=96 AD/ADRD care partners will be randomized to: usual care, n=32; MCP videos alone via RELOAD-C, n=32; or MCP videos + weekly groups via RELOAD-C, n=32. Care partners' outcomes will be assessed at baseline, and 6-weeks and 3-months post-baseline. The investigators expect the effect sizes will be in the moderate range (.3). Feasibility is defined as: ≥ 75% consented, ≤ 30% drop-out, and 80% engagement with intervention. Reducing loneliness among care partners is of high public health significance and incorporating MCP in loneliness interventions is highly innovative. In sum, the investigators will enroll 15 care partners during Aim 1, 20 care partners during Aim 2, and 96 care partners during Aim 3.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* • Self-identify as the care partner of a community-dwelling (i.e. does not live in a nursing home or facility) person with AD/ADRD (diagnosis confirmed via the patients' electronic health record when possible)

  * report that their role as a care partner is not related to their employment (i.e. they are a family member or friend of the patient)
  * age 18 or older
  * English-speaking
  * competency to participate
  * access to a telephone, computer, Internet and email
  * care partners must be lonely, defined as scoring ≥35 on the UCLA Loneliness Scale

Exclusion Criteria:

* Unable to communicate in English
* Under the age of 18
* only one care partner per patient will be allowed to participate
* could not have participated in previous Aims (1 or 2) of this study

Conditions2

Alzheimer's DiseaseLoneliness

Locations4 sites

Northwell Health, Institute of Health System Science
Manhasset, New York, 10022
Allison Marziliano, PhDamarzilian@northwell.edu
Geriatrics and Palliative Medicine
New Hyde Park, New York, 11042
Allison Marziliano, PhDamarzilian@northwell.edu
Geriatric Medicine, Lenox Hill Hospital
New York, New York, 10075
Allison Marziliano, PhDamarzilian@northwell.edu
Staten Island University South Hospital
Staten Island, New York, 10309

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.